| AMPAC | American Medical Political Action Committee |
|---|---|
| CMD | campomelic dysplasia; camptomelic dwarfism; cartilage matrix deficiency; chief medical director; chi... |
| comp | comparative; compensation, compensated; complaint; complete; composition; compound, compounded; comp... |
| DCM | dichloromethane; dichloromethotrexate; dilated cardiomyopathy; Doctor of Comparative Medicine; dyssy... |
| ISCP | infection surveillance and control program; International Society of Comparative Pathology |
| CGH | Comparative Genomic Hybridisation |
|---|---|
| CoMFA | Comparative Molecular Field Analysis |
| CGH | Comparative genome hybridization |
| CES-D | Center for Epidemiologic Studies - Depression |
| CES-D | Center for Epidemiologic Studies - Depression Scale |
| anatomy, comparative | The comparative study of animal structure with regard to homologous organs or parts. (12 Dec 1998) |
|---|---|
| comparative anatomy | The comparative study of animal structure with regard to homologous organs or parts. (05 Mar 2000) |
| comparative medicine | A field of study concentrating on similarities and differences between veterinary medicine and human medicine. (05 Mar 2000) |
| comparative pathology | The pathology of diseases of animals, especially in relation to human pathology. (05 Mar 2000) |
| comparative physiology | The science concerned with the differences in the vital processes in different species of organisms, particularly with a view to the adaptation of the processes to the specific needs of the species, to illuminating the evolutionary relationships among different species, or to establishing other interspecific generalizations and relationships. (05 Mar 2000) |
| comparative psychology | A branch of psychology concerned with the study and comparison of the behaviour of organisms at different levels of phylogenic development to discover developmental trends. (05 Mar 2000) |
| psychology, comparative | The branch of psychology concerned with similarities or differences in the behaviour of different animal species or of different races or peoples. (12 Dec 1998) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|